Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

1.

Characteristics and management of gout patients in Europe: data from a large cohort of patients.

Richette P, Flipo RN, Patrikos DK.

Eur Rev Med Pharmacol Sci. 2015 Feb;19(4):630-9.

2.

Giant cell arteritis occurring during psoriatic arthritis treated by adalimumab.

Corli J, Lemeunier L, Le Gouellec N, Flipo RM.

Joint Bone Spine. 2015 Feb 13. pii: S1297-319X(14)00268-1. doi: 10.1016/j.jbspin.2014.11.003. [Epub ahead of print] No abstract available.

PMID:
25686529
3.

AA amyloidosis treated with tocilizumab: case series and updated literature review.

Courties A, Grateau G, Philippe P, Flipo RM, Astudillo L, Aubry-Rozier B, Fabreguet I, Fahd W, Fain O, Guggenbuhl P, Hachulla E, Papo T, Richez C, Sibilia J, Morel J, Berenbaum F, Sellam J; on behalf of the Club Rhumatismes Inflammation and the REGATE Registry.

Amyloid. 2015 Jan 14:1-9. [Epub ahead of print]

PMID:
25585627
4.

Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patients.

Lefèvre G, Meyer A, Launay D, Machelart I, DeBandt M, Michaud J, Tournadre A, Godmer P, Kahn JE, Behra-Marsac A, Timsit MA, Schleinitz N, Wendling D, Melac-Ducamp S, Boyer P, Peretz A, Lequerré T, Richez C, Stervinou-Wemeau L, Morell-Dubois S, Lambert M, Dubucquoi S, Wallaert B, Benveniste O, Flipo RM, Hatron PY, Sibilia J, Hachulla E, Hervier B; on behalf of the Club Rhumatismes, Inflammation.

Rheumatology (Oxford). 2014 Oct 27. pii: keu404. [Epub ahead of print]

PMID:
25349440
5.

Treatment response, drug survival and safety of anti-tumour necrosis factor α therapy in 193 patients with psoriatic arthritis: a twelve-year "real life" experience.

Soubrier AS, Bele-Philippe P, Cortet B, Ramdane-Sebbane N, Bacle-Boutry MA, Lemeunier L, Flipo RM, Paccou J.

Joint Bone Spine. 2015 Jan;82(1):31-7. doi: 10.1016/j.jbspin.2014.08.001. Epub 2014 Oct 11.

PMID:
25311253
6.

Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registry.

Payet S, Soubrier M, Perrodeau E, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Gottenberg JE, Mariette X.

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1289-95.

PMID:
25299001
7.

Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohort.

Bacconnier L, Rincheval N, Flipo RM, Goupille P, Daures JP, Boulenger JP, Combe B.

Rheumatology (Oxford). 2015 Mar;54(3):520-7. doi: 10.1093/rheumatology/keu371. Epub 2014 Sep 14.

PMID:
25224416
8.

Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.

Mouterde G, Lukas C, Goupille P, Flipo RM, Rincheval N, Daurès JP, Combe B.

J Rheumatol. 2014 Aug;41(8):1614-22. doi: 10.3899/jrheum.130884. Epub 2014 Jul 15.

PMID:
25028372
9.

Treatment of nongout joint deposition diseases: an update.

Pascart T, Richette P, Flipo RM.

Arthritis. 2014;2014:375202. doi: 10.1155/2014/375202. Epub 2014 May 8. Review.

10.

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).

Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M, Cerato MH, Pouplin S, Flipo RM, Chabrefy L, Mouterde G, Euller-Ziegler L, Schaeverbeke T, Fautrel B, Saraux A, Chary-Valckenaere I, Chales G, Dernis E, Richette P, Mariette X, Berenbaum F, Sibilia J, Ravaud P.

Ann Rheum Dis. 2014 May 28. pii: annrheumdis-2013-204733. doi: 10.1136/annrheumdis-2013-204733. [Epub ahead of print]

11.

Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry.

Couderc M, Gottenberg JE, Mariette X, Pereira B, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Soubrier M; Club Rhumatismes et Inflammations.

Rheumatology (Oxford). 2014 Oct;53(10):1788-93. doi: 10.1093/rheumatology/keu176. Epub 2014 May 11.

PMID:
24821852
12.

Identification of patients with gout: elaboration of a questionnaire for epidemiological studies.

Richette P, Clerson P, Bouée S, Chalès G, Doherty M, Flipo RM, Lambert C, Lioté F, Poiraud T, Schaeverbeke T, Bardin T.

Ann Rheum Dis. 2014 May 5. doi: 10.1136/annrheumdis-2013-204976. [Epub ahead of print]

PMID:
24796335
13.

Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice.

Frazier-Mironer A, Dougados M, Mariette X, Cantagrel A, Deschamps V, Flipo RM, Logeart I, Schaeverbeke T, Sibilia J, Le Loët X, Combe B.

Joint Bone Spine. 2014 Jul;81(4):352-9. doi: 10.1016/j.jbspin.2014.02.014. Epub 2014 Apr 8.

PMID:
24721422
14.

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.

Ritchlin C, Rahman P, Kavanaugh A, McInnes IB, Puig L, Li S, Wang Y, Shen YK, Doyle MK, Mendelsohn AM, Gottlieb AB; PSUMMIT 2 Study Group.

Ann Rheum Dis. 2014 Jun;73(6):990-9. doi: 10.1136/annrheumdis-2013-204655. Epub 2014 Jan 30.

15.

Gout in French Polynesia: a survey of common practices.

Pascart T, Oehler E, Flipo RM.

Joint Bone Spine. 2014 Jul;81(4):374-5. doi: 10.1016/j.jbspin.2013.12.007. Epub 2014 Jan 23. No abstract available.

PMID:
24462131
16.

Autoimmune thyroid disorders during anti-TNF alpha therapy: coincidence, paradoxical event or marker of immunogenicity?

Pascart T, Ducoulombier V, Roquette D, Perimenis P, Coquerelle P, Maury F, Baudens G, Morel G, Deprez X, Flipo RM, Houvenagel E.

Joint Bone Spine. 2014 Jul;81(4):369-70. doi: 10.1016/j.jbspin.2013.11.007. Epub 2013 Dec 31. No abstract available.

PMID:
24387973
17.

Revisiting comorbidities in gout: a cluster analysis.

Richette P, Clerson P, Périssin L, Flipo RM, Bardin T.

Ann Rheum Dis. 2015 Jan;74(1):142-7. doi: 10.1136/annrheumdis-2013-203779. Epub 2013 Oct 9.

PMID:
24107981
18.

Gout: from international guidelines to current practice. Results from a physician questionnaire.

Pascart T, Flipo RM.

Clin Rheumatol. 2013 Nov;32(11):1693-4. doi: 10.1007/s10067-013-2402-4. No abstract available.

PMID:
24077902
19.

Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.

Combe B, Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loët X, Logeart I, Mariette X, Meyer O, Ravaud P, Saraux A, Schaeverbeke T, Sibilia J.

J Rheumatol. 2013 Oct;40(10):1650-7. doi: 10.3899/jrheum.121515. Epub 2013 Aug 15.

PMID:
23950185
20.

Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registry.

Godot S, Gottenberg JE, Paternotte S, Pane I, Combe B, Sibilia J, Flipo RM, Schaeverbeke T, Ravaud P, Toussirot E, Berenbaum F, Mariette X, Wendling D, Sellam J.

Arthritis Care Res (Hoboken). 2013 Nov;65(11):1874-9.

PMID:
23754822
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk